Corpus Intelligence IC Memo — NORTHWEST TEXAS HOSPITAL 2026-04-26 08:03 UTC
IC Memo — NORTHWEST TEXAS HOSPITAL
Investment Committee Memorandum | TX | 341 beds | Grade C | EBITDA uplift $28.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NORTHWEST TEXAS HOSPITAL

CCN 450209 | POTTER, TX | 341 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

NORTHWEST TEXAS HOSPITAL is a 341-bed suburban community hospital in POTTER, TX with $382.7M in net patient revenue and a 11.5% operating margin. The hospital serves a payer mix of 16.9% Medicare, 6.4% Medicaid, and 76.8% commercial.

Thesis: Platform Growth. Our ML models identify $28.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.5% to 18.8% (+736bps).

Net Revenue HCRIS$382.7M
Current EBITDA COMPUTED$43.8M
Operating Margin COMPUTED11.5%
Occupancy HCRIS61.6%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS13.8%
Distress Probability ML44.7%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
112
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 11.5% places it above the state median. Among 112 size-comparable peers (170-682 beds), the median margin is 4.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (170-682), prioritizing same-state peers. 112 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NORTHWEST TEXAS HOSPITAL (Target)TX341$382.7M11.5%
SCOTT AND WHITE MEMORIAL HOSPITX616$1.85B-10.5%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
COOK CHILDRENS MEDICAL CENTERTX423$1.51B16.5%
CHI ST LUKES HEALTH BAYLOR MEDTX628$1.10B-9.5%
UNIVERSITY HEALTH SYSTEMTX657$1.10B-50.0%
TX HLTH HARRIS METHODIST HOSPITX653$1.03B4.1%
CHRISTUS MOTHER FRANCES HOSP-TTX518$971.6M-17.0%
MEDICAL CITY PLANOTX573$936.8M40.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $28.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.0M+210bp18mo
Cost to Collect4.5%2.5%$7.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.7M+122bp9mo
Clean Claim Rate88.0%96.0%$245K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.0M
Cost to Collect
$7.7M
Denial Rate Reduction
$7.6M
A/R Days Reduction
$4.7M
Clean Claim Rate
$245K
Total EBITDA Uplift$28.2M
Current EBITDA$43.8M
+ RCM Uplift+$28.2M
Pro Forma EBITDA$72.0M
Current Margin11.5%
Pro Forma Margin18.8%
WC Released (1x)$14.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$67.4M$570.8M8.46x53.3%
Base (11x exit)10.0x11.0x$67.4M$649.8M9.64x57.3%
Bull Case9.0x11.0x$60.7M$764.7M12.60x66.0%
Bull (12x exit)9.0x12.0x$60.7M$852.1M14.04x69.6%
Bear Case11.0x10.0x$74.2M$408.1M5.50x40.6%
Bear (11x exit)11.0x11.0x$74.2M$473.0M6.38x44.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 112 hospitals with 170-682 beds
  • Same-state prioritization (n=113)
  • Comp margins: P25=-8.0% / P50=4.6% / P75=14.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.